Bayer to buy VC-backed vitamin company Care/of: Bloomberg
Bayer has agreed to acquire vitamin company Care/of, reported Bloomberg. The news outlet noted that the transaction will put Care/of at a $225 million valuation.
Bayer has agreed to acquire vitamin company Care/of, reported Bloomberg. The news outlet noted that the transaction will put Care/of at a $225 million valuation.
Copyright PEI Media
Not for publication, email or dissemination